---
schema_version: "secwatch.filing_event.v1"
accession: "0001174947-23-000915"
form_type: "8-K"
ticker: "CNMD"
cik: "0000816956"
company_name: "CONMED Corp"
filed_at: "2023-07-26T23:59:59+00:00"
generated_at: "2026-06-13T02:34:46.554563+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CONMED Q2 sales +14.6% to $317.7M, adj. EPS $0.83, raises FY guidance

## Summary
- GAAP diluted EPS $0.43 vs loss of $5.65; adjusted diluted EPS $0.83, +9.2% YoY.
- Revenue $317.7M (+14.6% as reported, +16.6% constant currency); acquisitions added ~400 bps.
- Domestic sales +17.1%; International sales +11.7% as reported (+16.0% constant currency).
- Orthopedic Surgery +17.1%, General Surgery +12.6% as reported.
- FY 2023 revenue guidance raised to $1.230-1.260B; adjusted EPS guidance raised to $3.40-3.55.

## SEC filing metadata
- accession: 0001174947-23-000915
- form_type: 8-K
- ticker: CNMD
- cik: 0000816956
- company_name: CONMED Corp
- filed_at: 2023-07-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/816956/000117494723000915/0001174947-23-000915-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/816956/000117494723000915/form8k-30543_cnmd.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001174947-23-000915
- JSON: https://secwatch.observer/filing/0001174947-23-000915.json
- Plain text: https://secwatch.observer/filing/0001174947-23-000915.txt

## Key facts
- Earnings Releases
  CONMED Corp reported second quarter ended June 30, 2023 results: revenue $317.7 million, net income $13,732, EPS $0.43. Guidance raised.
  - Period: second quarter ended June 30, 2023
  - Revenue: $317.7 million
  - Net income: $13,732
  - EPS: $0.43
  - Guidance: raised
  - Result: reported results
  source text: Florida, July 26, 2023 – CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Highlights · Sales of $317.7 million increased 14.6% year over year as reported and 16.6% in constant currency. Acquisitions contributed approximately 400 basis points of growth. · Domestic revenue increased 17.1%
  evidence_url: https://www.sec.gov/Archives/edgar/data/816956/000117494723000915/0001174947-23-000915-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.